Literature DB >> 16364036

Serum concentrations of high-mobility group box chromosomal protein 1 before and after exposure to the surgical stress of thoracic esophagectomy: a predictor of clinical course after surgery?

K Suda1, Y Kitagawa, S Ozawa, Y Saikawa, M Ueda, E Abraham, M Kitajima, A Ishizaka.   

Abstract

High-mobility group box chromosomal protein 1 (HMGB-1) has recently been shown as an important late mediator of endotoxin shock, intra-abdominal sepsis, and acute lung injury. However, its role in the systemic inflammatory response syndrome after major surgical stress, which may lead to multiple organ dysfunction syndrome, has not been thoroughly investigated. We hypothesized that serum HMGB-1 participates in the pathogenesis of postoperative organ system dysfunction after exposure to major surgical stress. A prospective clinical study was performed to consecutive patients (n = 24) with carcinoma of the thoracic esophagus who underwent transthoracic esophagectomy with three field lymph node resection between 1998 and 2003 at Keio University Hospital, Japan. Serum HMGB-1 concentrations were measured by enzyme-linked immunosorbent assay. Preoperative serum HMGB-1 levels correlated with postoperative duration of SIRS, mechanical ventilation, and intensive care unit stay. Three of the 24 patients had serious postoperative complications: sepsis in two, and acute lung injury in one. Serum HMGB-1 levels in patients without complications increased within the first 24 h postoperatively, remained high during postoperative days 2-3, and then decreased gradually by postoperative day 7. In patients with serious complications, serum HMGB-1 was significantly higher than that found in patients without postoperative complications at every time point except postoperative day 2. Preoperative serum HMGB-1 concentration seems to be an important predictor of the postoperative clinical course. Transthoracic esophagectomy induces an increase in HMGB-1 in serum even in patients without complications. Postoperative serum HMGB-1 concentrations were higher in patients who developed complications, and may be a predictive marker for complications in this setting.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16364036     DOI: 10.1111/j.1442-2050.2006.00529.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  17 in total

1.  Impact of serum high-mobility group box 1 protein elevation on oxygenation impairment after thoracic aortic aneurysm repair.

Authors:  Takashi Kohno; Toshihisa Anzai; Hideyuki Shimizu; Hidehiro Kaneko; Yasuo Sugano; Shingo Yamada; Tsutomu Yoshikawa; Akitoshi Ishizaka; Ryohei Yozu; Satoshi Ogawa
Journal:  Heart Vessels       Date:  2010-10-30       Impact factor: 2.037

2.  Plasma high-mobility group box 1 as an indicator of surgical stress.

Authors:  Atsushi Osoegawa; Tokujiro Yano; Takeharu Yamanaka; Tetsuzo Tagawa; Fumihiro Shoji; Ichiro Yoshino; Akinobu Taketomi; Hiroyuki Ito; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  Surg Today       Date:  2011-07-12       Impact factor: 2.549

Review 3.  High-mobility-group box chromosomal protein 1 as a new target for modulating stress response.

Authors:  Koichi Suda; Hiroya Takeuchi; Akitoshi Ishizaka; Yuko Kitagawa
Journal:  Surg Today       Date:  2010-06-26       Impact factor: 2.549

4.  Anti-high-mobility group box chromosomal protein 1 antibodies improve survival of rats with sepsis.

Authors:  Koichi Suda; Yuko Kitagawa; Soji Ozawa; Yoshiro Saikawa; Masakazu Ueda; Masahito Ebina; Shingo Yamada; Satoru Hashimoto; Shinji Fukata; Edward Abraham; Ikuro Maruyama; Masaki Kitajima; Akitoshi Ishizaka
Journal:  World J Surg       Date:  2006-09       Impact factor: 3.352

5.  Prognostic impact of clinical course-specific mRNA expression profiles in the serum of perioperative patients with esophageal cancer in the ICU: a case control study.

Authors:  Shunsaku Takahashi; Norimasa Miura; Tomomi Harada; ZhongZhi Wang; Xinhui Wang; Hideyuki Tsubokura; Yoshiaki Oshima; Junichi Hasegawa; Yoshimi Inagaki; Goshi Shiota
Journal:  J Transl Med       Date:  2010-10-22       Impact factor: 5.531

6.  HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis.

Authors:  Sari Karlsson; Ville Pettilä; Jyrki Tenhunen; Raili Laru-Sompa; Marja Hynninen; Esko Ruokonen
Journal:  Intensive Care Med       Date:  2008-02-23       Impact factor: 17.440

7.  Elevation of high-mobility group box 1 after clinical autologous islet transplantation and its inverse correlation with outcomes.

Authors:  Takeshi Itoh; Shuichi Iwahashi; Mazhar A Kanak; Masayuki Shimoda; Morihito Takita; Daisuke Chujo; Yoshiko Tamura; Ana M Rahman; Wen Y Chung; Nicholas Onaca; P Toby H Coates; Ashley R Dennison; Bashoo Naziruddin; Marlon F Levy; Shinichi Matsumoto
Journal:  Cell Transplant       Date:  2012-12-04       Impact factor: 4.064

Review 8.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

9.  Early release of high mobility group box nuclear protein 1 after severe trauma in humans: role of injury severity and tissue hypoperfusion.

Authors:  Mitchell J Cohen; Karim Brohi; Carolyn S Calfee; Pamela Rahn; Brian B Chesebro; Sarah C Christiaans; Michel Carles; Marybeth Howard; Jean-François Pittet
Journal:  Crit Care       Date:  2009-11-04       Impact factor: 9.097

Review 10.  Potential mechanisms of tumor progression associated with postoperative infectious complications.

Authors:  Hironori Tsujimoto; Minako Kobayashi; Hidekazu Sugasawa; Satoshi Ono; Yoji Kishi; Hideki Ueno
Journal:  Cancer Metastasis Rev       Date:  2021-01-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.